NCT02483104 - Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

July 31, 2016

Conditions

Ovarian Cancer

Interventions

DRUG

veliparib

Veliparib will be given orally, twice daily on Days 1-21, every 21 days.

DRUG

carboplatin

Carboplatin will be administered on Day 1 of each cycle, intravenously.

DRUG

paclitaxel

Paclitaxel will be administered on Days 1, 8, 15 of each cycle, intravenously.

Trial Locations (3)

Site Reference ID/Investigator# 128815, Kurume-shi,Fukuoka

Site Reference ID/Investigator# 128997, Morioka

Site Reference ID/Investigator# 128058, Nagaizumi-cho